CPO-166

N/A

Report date: 2024/09/03 16:39:25

Base Information

Drug NameCPO-166
Drug Alias NameCPO166CPO-166
ClassificationBiologics
Mechanisms of ActionCyclin-dependent kinase 2 inhibitorsCyclin-dependent kinase 4 inhibitorsCyclin-dependent kinase 6 inhibitors
TargetsCyclin-dependent kinase 2Cyclin-dependent kinase 4Cyclin-dependent kinase 6
Therapy Area/IndicationsMetastatic breast cancer
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesConjupro Biotherapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesConjupro Biotherapeutics Inc
Inactive CompaniesN/A
Active IndicationsMetastatic breast cancer
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A